Impact of COVID-19 on risks and deaths of non-communicable diseases in the Western Pacific region

Xu, Xiaoyue; Shi, Zumin; Zhou, Lihui; Lin, Jing; Atlantis, Evan; Chen, Xinguang; Hussain, Akhtar; Wang, Youfa; Wang, Yaogang

doi:10.1016/j.lanwpc.2023.100795

Cited by 6 publications

(1 citation statement)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Third, the COVID-19 pandemic overlapped with our research period from 2020 to 2021 and may have an effect on the all-cause mortality. However, its impact could be considered negligible, as China experienced extremely low life expectancy losses, COVID-19 mortality, and excess mortality [ 37 , 38 ]. Lastly, we focused on a limited range of mortality types.…”

Section: Discussionmentioning

confidence: 99%

The Association of Plasma Homocysteine Concentrations with a 10-Year Risk of All-Cause and Cardiovascular Mortality in a Community-Based Chinese Population

Liang,

Li,

Chen

et al. 2024

Nutrients

View full text Add to dashboard Cite

This study is aimed to examine the association of plasma homocysteine (Hcy) concentrations with a 10-year risk of all-cause and cardiovascular (CV) mortality and to explore the modification effect of methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism. This study included 5200 participants from a community-based Chinese population. Cox proportional hazard regression models were used to analyze the associations of Hcy and MTHFR C677T genotype with all-cause and CV mortality. The possible modification effect of the MTHFR C677T genotype on the Hcy–mortality relationship was assessed. The individuals with Hcy concentrations ≥ 10 μmol/L had a significantly higher risk of all-cause mortality compared to those with Hcy < 10 μmol/L (hazard ratio [HR]: 1.72, 95% confidence interval [CI]: 1.11–2.68, p = 0.015). The risk of CV mortality increased by 2% per 1 μmol/L Hcy increment (HR: 1.02, 95% CI: 1.00–1.03, p = 0.036). Despite the MTHFR genotype alone not being correlated with the mortality, the relationship between Hcy and all-cause mortality was significant in the CC genotype compared with CT/TT genotype (p for interaction = 0.036). Elevated plasma Hcy concentrations were associated with an increased 10-year risk of all-cause and CV mortality among the Chinese population. MTHFR C677T genetic polymorphism could modify the association between Hcy and all-cause mortality.

show abstract

Section: Discussionmentioning

confidence: 99%